BRAINSTORM CELL THERAPEUTICS INC.

For the period ended Dec 31, 2025. Filed Mar 31, 2026.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed Mar 31, 2026

BCLI$1.14-7.3%Stored close · as of Jul 8, 2026

Opening this filing…